Form D · Biotechnology
ACCENTIA BIOPHARMACEUTICALS INC
Tampa, FL · CIK 0001310094
Offering snapshot reported Jun 25, 2012 · SEC filing
- Reported sold
- $375K Offering amount: $375K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2012 | Initial | $375,000 | No comparison | 10 | SEC filing |
| Feb 8, 2012 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Mar 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 16, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 19, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 9, 2006 | Paper | Not reported | No comparison | Not reported | |
| Jul 12, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 10, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 10, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 13, 2004 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 10, 2004 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 21, 2004 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 3, 2003 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180216
$225,000 for number of shares issued and $150,000 for 535,716 warrants with an exercise price of $0.28 per share.
Source: Form D, filed Jun 25, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas M. Calder | Executive |
| Christopher C. Chapman | Director |
| Samuel S. Duffey | Executive |
| Garrison J. Hasara | Executive |
| Edmund C. King | Director |
| James A. Mc Nulty | Executive |
| Francis E. O'donnell, Jr. | Director, Executive |
| William S. Poole | Director |
| Carlos F. Santos | Executive |
| David M. Schubert | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
324 South Hyde Park Ave Suite 350
Tampa, FL, 33606
Tampa, FL, 33606